HealthMore in Health→
In vivo CAR-T dominates conference attention, but the field remains preclinical
Key Takeaways
- Endpoints News says in vivo CAR-T was a major theme at the ASGCT annual meeting in Boston.
- The same report stresses that the work is still preclinical.
- The contrast between conference buzz and early-stage evidence is the main reason the story matters.
DE
DT Editorial Team··via endpoints.news